PMV Pharmaceuticals Inc. (PMVP) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    PMV Pharmaceuticals Inc.

    NASDAQ: PMVP · Real-Time Price · USD
    1.48
    0.08 (5.71%)
    At close: Sep 26, 2025, 3:59 PM
    1.43
    -3.38%
    After-hours: Sep 26, 2025, 05:40 PM EDT

    PMV Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 40.88M 37.71M 108.3M 172.47M
    Short-Term Investments
    		 128.58M 165.35M 132.76M 124.7M
    Long-Term Investments
    		 13.84M 25.5M 2.5M 16.91M
    Other Long-Term Assets
    		 235K 190K 313K 221K
    Receivables
    		 n/a n/a n/a n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 6.2M 4.35M 5.95M 822K
    Total Current Assets
    		 175.66M 207.41M 247.01M 301.29M
    Property-Plant & Equipment
    		 1.55M 19.05M 20.49M 13.15M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 15.63M 44.74M 23.3M 30.28M
    Total Assets
    		 191.29M 252.15M 270.31M 331.57M
    Account Payables
    		 6.58M 3.24M 3M 3.19M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 352K n/a 528K 403K
    Other Current Liabilities
    		 5M 4.5M 3.88M 4.43M
    Total Current Liabilities
    		 14.37M 14.03M 10.83M 12.22M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 838K 12.43M 13.45M 10.79M
    Total Liabilities
    		 15.21M 26.46M 24.28M 23.01M
    Total Debt
    		 1.19M 13.29M 13.98M 11.19M
    Book Value
    		 176.08M 225.69M 246.03M 308.56M
    Book Value Per Share
    		 3.41 4.70 5.40 6.84
    Common Stock
    		 n/a n/a n/a n/a
    Retained Earnings
    		 -368.71M -310M -241.04M -167.73M
    Comprehensive Income
    		 139K 224K -445K -78K
    Shareholders Equity
    		 176.08M 225.69M 246.03M 308.56M
    Total Investments
    		 142.42M 190.86M 135.25M 141.61M

    Add to Watchlist